Thursday, Feb 15, 2024 · SEC filings
What the smart money revealed on Feb 15
749 insider filings came in. We hid 73 planned (10b5-1) sellers and 562 people whose filings were routine, like grants and tax withholding.
3 insiders at Azitra (AZTR) bought $105K of stock
Roles: CEO, CFO, COO. Several insiders buying in the same few days is rare.
RxSight (RXST) Director Juliet Tammenoms Bakker bought $407K
8,000 shares on the open market. Not a grant or an option exercise.
Agenus (AGEN) Chairman and CEO Garo Armen bought $325K
500,000 shares on the open market. Not a grant or an option exercise.
Texas Capital Bancshares (TCBI) Director Robert Stallings bought $226K
4,000 shares on the open market. Not a grant or an option exercise. Their past buys: 7 of 9 checked quarters beat the typical stock 6 months later.
Princeton Bancorp (BPRN) Director Martin Tuchman bought $158K
5,014 shares on the open market. Not a grant or an option exercise. Their past buys: 7 of 9 checked quarters beat the typical stock 6 months later.
Merck (MRK) Chairman Robert Davis sold $29.5M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 348,327 shares directly.
Loews (L) Director Andrew Tisch sold $18.3M
Not marked as a planned 10b5-1 sale. Sold 23% of the shares they held directly. Still holds 820,886 shares.
Sphere Entertainment (SPHR) EVP David Byrnes sold $197K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 16 more real buys
Show 72 more real sales
13F season
Holdings as of Dec 31, 2023 were due Feb 14
49 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Feb 9–15
Open-market buys by officers and directors, filed in the 7 days up to Feb 15.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.